Industry News

Harrow Acquires Santen’s Branded Ophthalmic Portfolio

Harrow announced the signing of agreements with affiliates of Santen Pharmaceutical Co to acquire certain U.S. and Canadian commercial rights for a range of branded eyecare products. The acquisition marks a significant milestone for Harrow, as it broadens the company's product portfolio and enhances its presence in the U.S. ophthalmic...